Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_assertion type Assertion NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_head.
- NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_assertion description "[Epidermal growth factor receptor (EGFR) transmembrane glycoprotein has been demonstrated to be overexpressed in pancreatic cancer, and it correlates with more advanced disease, poor survival, and the presence of metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_provenance.
- NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_assertion evidence source_evidence_literature NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_provenance.
- NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_assertion SIO_000772 23560505 NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_provenance.
- NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_assertion wasDerivedFrom befree-2016 NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_provenance.
- NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_assertion wasGeneratedBy ECO_0000203 NP1066837.RA9hIdIr4KxET1V-2Fq85JJ_9Lph0Wrh06MYj-RuQh_iA130_provenance.